Relic Pharma Limited

Relic Pharma Limited - financial services in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U67120MH1995PLC088000 Incorporated 04 May 1995 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company financial services
Data last updated
Revenue · FY 2023
-
▼ 100.00% YoY
EBITDA · FY 2023
*****
▲ 24.51% YoY
Net profit · FY 2023
*****
▼ 189.29% YoY
Authorised capital
₹3.25 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
31 yrs
Est. 1995
Last financials
Mar 2024
Balance sheet date

About Relic Pharma Limited

Data last updated: 23 December 2025

Relic Pharma Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Relic Technologies Limited. It specialises in brokerage and trading services, a part of the broader financial services sector. Incorporated on 04 May 1995, the company has been in operation for over 31 years.

Registered with ROC Mumbai under CIN U67120MH1995PLC088000.

Capital: an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Hemant Kantilal Choksey and Baijoo Madhusudan Raval.

Last AGM: 19 August 2024. Financial statements filed for year ended 31 March 2024. Office: J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002.

It operates as a subsidiary of Relic Technologies Limited.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Relic Pharma Limited
CIN U67120MH1995PLC088000
Registration Number 088000
Incorporation Date 04 May 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 19 August 2024
Date of Balance Sheet 31 March 2024
Parent Company Relic Technologies Limited
Compliance Status Active Compliant
Key People
Hemant Kantilal Choksey Director Baijoo Madhusudan Raval Director Uday Madhusudan Raval Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002
  • Industry
    Financial Services, Brokerage & Trading Services
Company report
Relic Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Relic Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Relic Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Relic Pharma Limited

Relic Pharma Limited has one previous CIN (Corporate Identification Number): U67120MH2004PTC088000. The current CIN is U67120MH1995PLC088000, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U67120MH1995PLC088000 Current
U67120MH2004PTC088000 Previous

Business Activity of Relic Pharma Limited

Relic Pharma Limited operates primarily in the financial and insurance service sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Financial and insurance Service ********* Other financial activities *********
********* Financial and insurance Service ********* Other financial activities *********

Auditor Details of Relic Pharma Limited

Relic Pharma Limited is audited by UDAY PASAD AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
UDAY PASAD AND ASSOCIATES blur-value blur-value blur-value

Board of Directors of Relic Pharma Limited

Relic Pharma Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Hemant Kantilal Choksey Director 19 Apr 2014 12 Years 2 Months Current
Baijoo Madhusudan Raval
Also directs: Relic Technologies Limited, Arkaan Enterprises Private Limited
Director 04 May 1995 31 Years 2 Months Current
Uday Madhusudan Raval Director 04 May 1995 31 Years 2 Months Current
View all directors

Financials of Relic Pharma Limited FY 2024 filings available

Relic Pharma Limited reported revenue of ₹- (down -100.00% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
- ▼ -100.00%
Profit
***** ▼ -189.29%
EBITDA
***** ▲ 24.51%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Relic Pharma Limited

As of FY 2021, Relic Pharma Limited's shareholding pattern shows 99.93% by promoters, 0.07% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Relic Pharma Limited

Relic Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Relic Pharma Limited

View historical data on people associated with Relic Pharma Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Relic Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Relic Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Relic Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Relic Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Relic Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Relic Pharma Limited

MSME Payment Delays by Relic Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Relic Pharma Limited

Subsidiaries & Group Companies of Relic Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Relic Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Relic Pharma Limited

MCA Filings & Documents of Relic Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Relic Pharma Limited

Activity
19 Aug 2024
Relic Pharma Limited last Annual general meeting of members was held on 19 Aug 2024 as per latest MCA records.
Activity
31 Mar 2024
Relic Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Directors
19 Apr 2014
Hemant Kantilal Choksey was appointed as a Director on 19 Apr 2014 & has been associated with this company since 12 years 2 months.
Directors
04 May 1995
Baijoo Madhusudan Raval was appointed as a Director on 04 May 1995 & has been associated with this company since 31 years 2 months.
Directors
04 May 1995
Uday Madhusudan Raval was appointed as a Director on 04 May 1995 & has been associated with this company since 31 years 2 months.
Activity
04 May 1995
Relic Pharma Limited was registered on 04 May 1995 with Roc Mumbai & aged 31 years 2 months as per MCA records.

Frequently Asked Questions about Relic Pharma Limited

Relic Pharma Limited is an active public limited company in the financial services sector based in Mumbai, Maharashtra, India. It was incorporated on 04 May 1995 (31+ years old) and is registered under CIN U67120MH1995PLC088000.

The current directors of Relic Pharma Limited are:

The primary industry of Relic Pharma Limited is financial services. The company specifically operates in brokerage and trading services. The company is currently active in this sector.

Relic Pharma Limited can be reached at the registered office: J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002.

The authorised capital is ₹3.25 Cr, and the paid-up capital is ₹1 Cr.

The company has its registered office at J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available